United States: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Massachusetts Introduces Legislation To Regulate Pharmacy Benefit Managers

On February 3, 2026, the Massachusetts Center for Health Information and Analysis (CHIA) introduced a transformative new standard for Pharmacy Benefit Manager (PBM) reporting under 957 CMR 12.00.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

HTI-5: The Great Health IT Deregulation – What Healthcare Companies Need To Know Now

The Department of Health and Human Services (HHS), through the Assistant Secretary for Technology Policy/Office of the National...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Voices For Change: Leading A Top-tier Global Law Firm With Khalid Garousha (Podcast)

From arriving in the UK aged seven with limited English, to becoming the leader of one of the world's largest law firms, Khalid reflects on the values, resilience and moments of inflection that have defined his path.

United States Healthcare

AO

A&O Shearman

CMS Updates Pay, Price Rules And Adds New Quality Steps For 2026

The Centers for Medicare & Medicaid Services (CMS) are required to update and publish payment policies and rates for hospital outpatient departments and ambulatory surgery centers (ASCs) annually.

United States Healthcare

PD

Phelps Dunbar LLP

Better Together: A Pediatric Healthcare Affiliation

United States Healthcare

SR

McDermott Will & Schulte

HHS Provides Updated Model Notices Of Privacy Practices

United States Healthcare

KM

Katten Muchin Rosenman LLP

FDA Announces New Enforcement Policy On "No Artificial Colors" Food Labeling

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Time Flies! Cosmetic Manufacturing Facilities Are Due For FDA Registration Renewal

United States Healthcare

WR

Wiley Rein

A Settlement, Not A Sigh Of Relief: What The FTC's Express Scripts Deal Signals For Enforcement Risk

United States Healthcare

PL

Polsinelli LLP

What The Department Of Justice's 2025 FCA Recoveries Signal For 2026: Health Care, Cyber, And Customs

United States Healthcare

FL

Foley & Lardner

Healthcare Fraud: The Last Bastion Of Federal And State White-Collar Enforcement

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Consolidated Appropriations Act Introduces Sweeping Reforms For Pharmacy Benefit Managers

United States Healthcare

CM

Crowell & Moring LLP

OIG Issues Medicare Advantage Industry Segment-Specific Compliance Program Guidance, Creating Implications For Downstream Entities

United States Healthcare

DM

Duane Morris LLP

NSF Will Establish National Quantum And Nanotechnology Research Infrastructure; Letters Of Intent Are Due March 16, 2026

United States Healthcare

BC

Bergeson & Campbell

What Europe's Renewable Energy Struggles Can Teach U.S. Regulators About Dispute System Design

United States Litigation

J

JAMS

Signed, Sealed, But Not Delivered? Don't Wonder About Taxes Under New Postal Service Rules

United States Tax

N

Nossaman LLP

Colorado "Opt-Out" Litigation – Petition For Rehearing En Banc And Amicus Briefs In Support

United States Finance

BS

Ballard Spahr LLP

Federal Circuit: Priority Document That 'Broadly Outlines' Possible Structures Fails To Provide Adequate Written Description Support For Subgenus Of Linkers In Antibody-Drug Conjugate

United States IP

AG

Akin Gump Strauss Hauer & Feld LLP

Debt's Grip: What Consumer Bankruptcy Reveals About Financial Risk In America (Podcast)

United States Insolvency

BS

Ballard Spahr LLP

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Massachusetts Introduces Legislation To Regulate Pharmacy Benefit Managers

On February 3, 2026, the Massachusetts Center for Health Information and Analysis (CHIA) introduced a transformative new standard for Pharmacy Benefit Manager (PBM) reporting under 957 CMR 12.00.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FDA Announces New Enforcement Policy On "No Artificial Colors" Food Labeling

The U.S. Food and Drug Administration (FDA) continues its close review of federal regulations governing color additives used in food, drugs and cosmetics.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Time Flies! Cosmetic Manufacturing Facilities Are Due For FDA Registration Renewal

Manufacturers and processors of U.S.-distributed cosmetic products must renew their facility registration for the first time by July 1, 2026.

United States Healthcare

WR

Wiley Rein

A Settlement, Not A Sigh Of Relief: What The FTC's Express Scripts Deal Signals For Enforcement Risk

United States Healthcare

PL

Polsinelli LLP

Healthcare Fraud: The Last Bastion Of Federal And State White-Collar Enforcement

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Consolidated Appropriations Act Introduces Sweeping Reforms For Pharmacy Benefit Managers

United States Healthcare

CM

Crowell & Moring LLP

Genetic Testing Enforcement Poised To Rise: What To Expect In The Coming Year

United States Healthcare

KM

Katten Muchin Rosenman LLP

Sweeping PBM Reforms Arrive: What The 2026 Federal Legislation Means For Pharmacies, Patients And Employers

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Express Scripts Settles PBM FTC Action And Must Make Fundamental Changes To PBM Model

United States Healthcare

GP

Goodwin Procter LLP

See more

Life Sciences, Biotechnology & Nanotechnology

FDA Announces New Enforcement Policy On "No Artificial Colors" Food Labeling

The U.S. Food and Drug Administration (FDA) continues its close review of federal regulations governing color additives used in food, drugs and cosmetics.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

NSF Will Establish National Quantum And Nanotechnology Research Infrastructure; Letters Of Intent Are Due March 16, 2026

The U.S. National Science Foundation (NSF) announced on February 13, 2026, that it is investing up to $100 million to establish a nationwide network of open-access research facilities for quantum and nanoscale technologies...

United States Healthcare

BC

Bergeson & Campbell

Life Sciences Dealmaking Accelerates In 2026: Key Insights From EY's Firepower M&A Report

According to Ernst and Young's (EY) 2026 Firepower M&A Report, dealmaking is accelerating — driven not by short-term market shifts, but by long-term strategic fundamentals.

United States Healthcare

SR

McDermott Will & Schulte

Genetic Testing Enforcement Poised To Rise: What To Expect In The Coming Year

United States Healthcare

KM

Katten Muchin Rosenman LLP

Samsung And Regeneron Settle Aflibercept BPCIA Case

United States Healthcare

GP

Goodwin Procter LLP

Reforms To FDA Requirements For Cell And Gene Therapy Products

United States Healthcare

GP

Goodwin Procter LLP

Oliver Twisted Again: After FDA's Court Losses, Congress Approves FDA's Standards On Orphan Drug Exclusivity

United States Healthcare

AV

Axinn Veltrop & Harkrider

2026 Top-of-Mind Issues For Life Sciences Companies

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

J.P. Morgan Healthcare Conference 2026: Recap And What To Watch

United States Healthcare

BS

Ballard Spahr LLP

See more

Healthcare

Massachusetts Introduces Legislation To Regulate Pharmacy Benefit Managers

On February 3, 2026, the Massachusetts Center for Health Information and Analysis (CHIA) introduced a transformative new standard for Pharmacy Benefit Manager (PBM) reporting under 957 CMR 12.00.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

HTI-5: The Great Health IT Deregulation – What Healthcare Companies Need To Know Now

The Department of Health and Human Services (HHS), through the Assistant Secretary for Technology Policy/Office of the National...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Voices For Change: Leading A Top-tier Global Law Firm With Khalid Garousha (Podcast)

From arriving in the UK aged seven with limited English, to becoming the leader of one of the world's largest law firms, Khalid reflects on the values, resilience and moments of inflection that have defined his path.

United States Healthcare

AO

A&O Shearman

CMS Updates Pay, Price Rules And Adds New Quality Steps For 2026

United States Healthcare

PD

Phelps Dunbar LLP

Better Together: A Pediatric Healthcare Affiliation

United States Healthcare

SR

McDermott Will & Schulte

HHS Provides Updated Model Notices Of Privacy Practices

United States Healthcare

KM

Katten Muchin Rosenman LLP

New York Federal Court Dismisses False Claims Act Suit Against COVID-19 Testing Facility Company, Without Prejudice

United States Criminal

AF

ArentFox Schiff

A Settlement, Not A Sigh Of Relief: What The FTC's Express Scripts Deal Signals For Enforcement Risk

United States Healthcare

PL

Polsinelli LLP

What The Department Of Justice's 2025 FCA Recoveries Signal For 2026: Health Care, Cyber, And Customs

United States Healthcare

FL

Foley & Lardner

See more

Latest Videos

See more

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Pay Transparency + The Power Of Preventive Strategies: Episode 3 — Pivoting Toward Preparation In The Life Sciences (Video)

JL

Jackson Lewis P.C.

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech (Video)

AP

Arnold & Porter

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More